Compound ID | 586
CE-129941
Class: Protein synthesis inhibitor
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and penicillin-resistant Streptococcus pneumoniae |
| Description: | Girard D, Finegan SM, Seibel SB, et al. In vivo pharmacology of CE-129,941, an orally active hygromycin A analog. 46th-Intersci-Conf-Antimicrobial-Agents-Chemother 2006;229 |
| Institute where first reported: | Pfizer, USA |
| Year first mentioned: | 2006 |
| Development status: | Experimental |
| External links: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.